Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer.
Saved in:
| Title: | Japanese nationwide observational multicenter study of tumor BRCA1/2 variant testing in advanced ovarian cancer. |
|---|---|
| Authors: | Oda K; Division of Integrative Genomics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan., Aoki D; Department of Obstetrics and Gynecology, Keio University School of Medicine, Tokyo, Japan., Tsuda H; Department of Basic Pathology, National Defense Medical College, Saitama, Japan., Nishihara H; Keio Cancer Center, Keio University School of Medicine, Tokyo, Japan., Aoyama H; Medical Department, AstraZeneca K.K., Osaka, Japan., Inomata H; Medical Department, AstraZeneca K.K., Osaka, Japan., Shimada M; Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Miyagi, Japan., Enomoto T; Department of Obstetrics and Gynecology, Niigata University Medical School, Niigata, Japan. |
| Source: | Cancer science [Cancer Sci] 2023 Jan; Vol. 114 (1), pp. 271-280. Date of Electronic Publication: 2022 Oct 18. |
| Publication Type: | Multicenter Study; Observational Study; Journal Article |
| Journal Info: | Publisher: Wiley Publishing on behalf of the Japanese Cancer Association Country of Publication: England NLM ID: 101168776 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1349-7006 (Electronic) Linking ISSN: 13479032 NLM ISO Abbreviation: Cancer Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1349-7006 |
|---|---|
| DOI: | 10.1111/cas.15518 |
